HIGHLIGHTS
- who: Valeriy Poroyko from the Institut(INSERM), France have published the research: Editorial: The human microbiome: A new frontier in personalized cancer therapy, in the Journal: Microbiome in Health and Disease, of 25/08/2022
- how: The remaining authors declare that the research was conducted in the absence of any commercial or financial Frontiers in Cellular and Infection Microbiology frontiersin.org
- future: The findings warrant future investigation to confirm whether the altered microbial communities secrete metabolic and immune-altering elements to cause these outcomes.
SUMMARY
The human microbiome: a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.